CAD 0.03
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | -100.0% |
2019 | 3031.00 CAD | -80.38% |
2018 | 15.45 Thousand CAD | -30.5% |
2017 | 22.23 Thousand CAD | -28.4% |
2016 | 31.05 Thousand CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - CAD | 0.0% |
2024 Q2 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 FY | - CAD | -100.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | -100.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q1 | 3031.00 CAD | 275.12% |
2019 FY | 3031.00 CAD | -80.38% |
2018 Q1 | 2395.00 CAD | 119.7% |
2018 FY | 15.45 Thousand CAD | -30.5% |
2018 Q4 | 808.00 CAD | -20.55% |
2018 Q3 | 1017.00 CAD | -90.94% |
2018 Q2 | 11.23 Thousand CAD | 368.94% |
2017 Q1 | - CAD | -100.0% |
2017 Q2 | 17.68 Thousand CAD | 0.0% |
2017 Q3 | 13.04 Thousand CAD | -26.21% |
2017 FY | 22.23 Thousand CAD | -28.4% |
2017 Q4 | -12.16 Thousand CAD | -193.21% |
2016 Q3 | 15.15 Thousand CAD | 102.49% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | 7482.00 CAD | 0.0% |
2016 FY | 31.05 Thousand CAD | 0.0% |
2016 Q4 | 8422.00 CAD | -44.41% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | NaN% |
Asep Medical Holdings Inc | 21.14 Thousand CAD | 100.0% |
BetterLife Pharma Inc. | - CAD | NaN% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | - CAD | NaN% |
Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 100.0% |
Defence Therapeutics Inc. | - CAD | NaN% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 100.0% |
Gemina Laboratories Ltd. | - CAD | NaN% |
Glow Lifetech Corp. | 43.93 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | - CAD | NaN% |
Pharmala Biotech Holdings Inc. | 532 Thousand CAD | 100.0% |
Doseology Sciences Inc. | 98.52 Thousand CAD | 100.0% |
MYND Life Sciences Inc. | - CAD | NaN% |
Nova Mentis Life Science Corp. | 28.34 Thousand CAD | 100.0% |
PharmaTher Holdings Ltd. | - CAD | NaN% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 100.0% |